-
EP1689857
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1689857
| EP1689857 - COMPOSITIONS COMPRISING FETAL LIVER CELLS AND METHODS USEFUL FOR HCV INFECTION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.02.2012 Database last updated on 30.07.2024 | Most recent event Tooltip | 10.02.2012 | Application deemed to be withdrawn | published on 14.03.2012 [2012/11] | Applicant(s) | For all designated states VERTEX PHARMACEUTICALS INCORPORATED 130 Waverly Street Cambridge, MA 02139 / US | [2006/33] | Inventor(s) | 01 /
BYRN, Randal 7 Pemberton Road Wayland, MA 01778 / US | [2006/33] | Representative(s) | Nargolwalla, Cyra, et al Cabinet Plasseraud ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR Paris / FR | [N/P] |
| Former [2006/33] | Nargolwalla, Cyra, et al Cabinet Plasseraud 65/67 rue de la Victoire 75440 Paris Cedex 09 / FR | Application number, filing date | 04812485.3 | 01.12.2004 | [2006/33] | WO2004US39964 | Priority number, date | US20030526411P | 01.12.2003 Original published format: US 526411 P | [2006/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005054450 | Date: | 16.06.2005 | Language: | EN | [2005/24] | Type: | A1 Application with search report | No.: | EP1689857 | Date: | 16.08.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.06.2005 takes the place of the publication of the European patent application. | [2006/33] | Search report(s) | International search report - published on: | EP | 16.06.2005 | Classification | IPC: | C12N5/08, C12N7/00, C12Q1/70, A01N1/02 | [2006/33] | CPC: |
A01N1/02 (EP,US);
A01N1/0221 (EP,US);
C12N5/067 (EP,US);
C12N2500/10 (EP,US);
C12N2500/14 (EP,US);
C12N2500/25 (EP,US);
C12N2500/36 (EP,US);
C12N2500/38 (EP,US);
C12N2500/90 (EP,US);
C12N2501/11 (EP,US);
C12N2501/18 (EP,US);
C12N2501/335 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/33] | Extension states | AL | 21.06.2006 | BA | 21.06.2006 | HR | 21.06.2006 | LV | 21.06.2006 | MK | 21.06.2006 | YU | 21.06.2006 | Title | German: | ZUSAMMENSETZUNGEN ENTHALTENDE FÖTALE LEBERZELLEN UND METHODEN ZUR HCV INFEKTION | [2006/33] | English: | COMPOSITIONS COMPRISING FETAL LIVER CELLS AND METHODS USEFUL FOR HCV INFECTION | [2006/33] | French: | COMPOSITIONS RENFERMANT DES CELLULES HEPATIQUES FOETALES, ET PROCEDES UTILES POUR LE TRAITEMENT DE L'INFECTION PAR LE VHC | [2006/33] | Entry into regional phase | 21.06.2006 | National basic fee paid | 21.06.2006 | Designation fee(s) paid | 21.06.2006 | Examination fee paid | Examination procedure | 21.06.2006 | Examination requested [2006/33] | 24.01.2008 | Despatch of a communication from the examining division (Time limit: M04) | 24.01.2008 | Despatch of a communication from the examining division (Time limit: M06) | 24.07.2008 | Reply to a communication from the examining division | 09.03.2011 | Despatch of a communication from the examining division (Time limit: M06) | 20.09.2011 | Application deemed to be withdrawn, date of legal effect [2012/11] | 27.10.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/11] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.01.2008 | Fees paid | Renewal fee | 27.12.2006 | Renewal fee patent year 03 | 24.12.2007 | Renewal fee patent year 04 | 24.12.2008 | Renewal fee patent year 05 | 28.12.2009 | Renewal fee patent year 06 | 27.12.2010 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 31.12.2011 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO02077206 (VERTEX PHARMA [US], et al) [X] 1-56 * pages 6,9-12, * * page 13; examples 1-6; claims 1-34 *; | [Y]WO9203046 (SOMATIX THERAPY CORP [US]) [Y] 1-5,7-12,14-17,23,25-28,30,32-53,55,56 * page 3, lines 15,16 * * page 4 * * examples 1,3 *; | [Y]EP0972828 (INST NAT SANTE RECH MED [FR]) [Y] 1-56 * the whole document *; | [Y] - TARASOV A I ET AL, "Phenotypic analysis and colony-forming activity of cryopreserved hematopoietic cells in human fetal liver.", EKSPERIMENTAL'NAYA ONKOLOGIYA, (200209), vol. 24, no. 3, ISSN 0204-3564, pages 180 - 183, XP002322700 [Y] 1-5,7-12,14-17,23,25-28,30,32-53,55,56 * page 181 * | [Y] - GRISCHENKO ET AL, "Sensitivity to a programmed and cyclic freeze-thawing of human embryonic liver cells of 7-12 weeks of gestation", PROBLEM IN CRYOBIOLOGY, UKRAINE, (2000), vol. 4, pages 37 - 44, XP009045781 [Y] 1-5,7-12,14-17,23,25-28,30,32-53,55,56 * page 38 * | [Y] - LAZARO CATHERINE A ET AL, "Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes.", HEPATOLOGY, (200311), vol. 38, no. 5, ISSN 0270-9139, pages 1095 - 1106, XP002322701 [Y] 1-56 * page 1096 * * page 1099 * * page 1103 * * page 1106 * DOI: http://dx.doi.org/10.1053/jhep.2003.50448 | [Y] - IACOVACCI S ET AL, "MOLECULAR CHARACTERIZATION AND DYNAMICS OF HEPATITIS C VIRUS REPLICATION IN HUMAN FETAL HEPATOCYTES INFECTED IN VITRO", HEPATOLOGY, WILLIAMS AND WILKINS, BALTIMORE, MD, US, (1997), ISSN 0270-9139, pages 1328 - 1337, XP002953740 [Y] 1-56 * the whole document * |